Tapping new tech helps marketers matchmake rare disease drugs for elusive patients

NEWS
/ Article

01-19-2022

Tapping new tech helps marketers matchmake rare disease drugs for elusive patients

by DeepIntent

Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty treatments.

In this article for Fierce Pharma, founder and CEO Chris Paquette discusses how data and technology like artificial intelligence can help.

More News

Article

What Pharma Marketers Are Saying About CTV This Upfront Season

5-1-2025

As upfront season kicks off, media buyers across industries are recalibrating their video strategies, determining both how much to spend and where to spend...

Article

The Future of Endemic Publishers and Programmatic

4-25-2025

In a vibrant session at AdLab 2025, a panel of industry leaders explored how endemic publishers are adapting to a rapidly evolving programmatic landscape....

Article

CTV Is Rewriting the Rules of Pharma Upfronts. Are You Ready?

4-18-2025

Pharma advertisers have long relied on TV for its unmatched scale and storytelling power. But as viewing habits evolve and demand for measurable results...